Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Clinical trial NCT05797597 · UNKNOWN
Trial details
- NCT number
- NCT05797597
- Sponsor
- Lucyna Mastalerz
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2025-02-28
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.